Your browser doesn't support javascript.
loading
Mass drug administration of ivermectin, diethylcarbamazine, plus albendazole compared with diethylcarbamazine plus albendazole for reduction of lymphatic filariasis endemicity in Papua New Guinea: a cluster-randomised trial.
Laman, Moses; Tavul, Livingstone; Karl, Stephan; Kotty, Bethuel; Kerry, Zebede; Kumai, Stephen; Samuel, Anna; Lorry, Lina; Timinao, Lincoln; Howard, S Cade; Makita, Leo; John, Lucy; Bieb, Sibauk; Wangi, James; Albert, Jeffrey M; Payne, Michael; Weil, Gary J; Tisch, Daniel J; Bjerum, Catherine M; Robinson, Leanne J; King, Christopher L.
Afiliación
  • Laman M; Papua New Guinea Institute for Medical Research, Goroka, Papua New Guinea.
  • Tavul L; Papua New Guinea Institute for Medical Research, Goroka, Papua New Guinea.
  • Karl S; Papua New Guinea Institute for Medical Research, Goroka, Papua New Guinea; Australian Institute of Tropical Health and Medicine, James Cook University, Smithfield, QLD, Australia.
  • Kotty B; Papua New Guinea Institute for Medical Research, Goroka, Papua New Guinea.
  • Kerry Z; Papua New Guinea Institute for Medical Research, Goroka, Papua New Guinea.
  • Kumai S; Papua New Guinea Institute for Medical Research, Goroka, Papua New Guinea.
  • Samuel A; Papua New Guinea Institute for Medical Research, Goroka, Papua New Guinea.
  • Lorry L; Papua New Guinea Institute for Medical Research, Goroka, Papua New Guinea.
  • Timinao L; Papua New Guinea Institute for Medical Research, Goroka, Papua New Guinea.
  • Howard SC; Center for Global Health and Diseases, Case Western Reserve University, Cleveland, OH, USA.
  • Makita L; National Department of Health, Waigani, Papua New Guinea.
  • John L; National Department of Health, Waigani, Papua New Guinea.
  • Bieb S; National Department of Health, Waigani, Papua New Guinea.
  • Wangi J; WHO Papua New Guinea, NTD Program, Waigani, Papua New Guinea.
  • Albert JM; Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA.
  • Payne M; Center for Global Health and Diseases, Case Western Reserve University, Cleveland, OH, USA.
  • Weil GJ; Department of Medicine, Washington University, St Louis, MO, USA.
  • Tisch DJ; Center for Global Health and Diseases, Case Western Reserve University, Cleveland, OH, USA; Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USA.
  • Bjerum CM; Center for Global Health and Diseases, Case Western Reserve University, Cleveland, OH, USA.
  • Robinson LJ; Papua New Guinea Institute for Medical Research, Goroka, Papua New Guinea; Burnet Institute, Melbourne, VIC, Australia; Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia.
  • King CL; Center for Global Health and Diseases, Case Western Reserve University, Cleveland, OH, USA; Veterans Affairs Research Administration, Cleveland, OH, USA. Electronic address: cxk21@case.edu.
Lancet Infect Dis ; 22(8): 1200-1209, 2022 08.
Article en En | MEDLINE | ID: mdl-35533701
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Filariasis Linfática / Filaricidas Tipo de estudio: Clinical_trials / Observational_studies / Prevalence_studies / Risk_factors_studies Idioma: En Revista: Lancet Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Filariasis Linfática / Filaricidas Tipo de estudio: Clinical_trials / Observational_studies / Prevalence_studies / Risk_factors_studies Idioma: En Revista: Lancet Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article